Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-24

FDA Approved: NORLIQVA — Original Application (CMP Pharma, Inc.)

View source ↗

Summary

FDA approved NORLIQVA (amlodipine) from CMP Pharma as an original application. The product is indicated for the treatment of hypertension and angina pectoris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NORLIQVA (AMLODIPINE)

Snippet

ORIG AP for NORLIQVA (AMLODIPINE)